针对帕金森病的社区拳击计划与量身定制的平衡训练的可行性:初步研究
Evan V Papa1,2, Kathryn E Sawyer1, James M Smoliga1
1Department of Rehabilitation Sciences, Tufts University School of Medicine, 800 5th Ave., Seattle, WA 98104, USA.
Brain sciences
|August 28, 2025
概括
这项研究探讨了帕金森病 (PD) 患者的拳击计划,发现它是可行的,并改善了平衡和运动能力. 降低跌倒的效果是不确定的,需要进一步的研究.
科学领域:
- 神经学
- 老年学
- 康复医学
背景情况:
- 帕金森病 (PD) 增加了由于姿势控制和感官整合受损的跌倒风险.
- 基于社区的拳击计划 (CBPs) 显示了改善PD患者力量和平衡的潜力.
- 加强CBP在减轻跌倒风险方面的作用需要进一步调查.
研究的目的:
- 评估一个以社区为基础的拳击计划 (CBP) 与帕金森病 (PD) 患者的个人平衡训练相结合的可行性.
- 探索这种增强的CBP对PD患者跌倒风险和相关功能结果的初步影响.
- 为未来临床试验的设计提供信息,以调查PD中预防跌倒的干预措施.
主要方法:
- 一项为期12周的前性队列研究,涉及20名轻度至中度PD患者.
- 参与者从事集体拳击,循环训练和基于感官互动缺陷的个人平衡训练.
- 结果包括自我报告的跌倒,平衡措施,步态和功能移动性评估.
主要成果:
- 在平衡和功能性移动方面观察到显著的改善,包括定时起床和起床,五次坐立测试和伯格平衡量.
- 4名参与者报告了跌倒的减少,而2名参与者报告了跌倒的增加,而其他参与者则报告没有变化.
- 这项干预表明了可行性和对特定功能措施的积极影响.
结论:
- 对于患有PD的人来说,将个性化平衡训练整合到CBP中是可行的.
- 增强的CBP可以改善PD患者的功能移动性和平衡.
- 需要进一步的研究来证实对降落的影响,并在更大的试验中确定疗效.
相关概念视频
01:24Parkinson's Disease: Treatment
376
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
376
01:15Parkinson's Disease: Overview
702
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
702